“The Clinical Translation of Cell and Gene Therapies: Q&A”

On Thursday, October 29, 2021 from 12-1pm Pacific Time (US and Canada)

Join us for a dialogue following a presentation by:
Mohamed Abou-el-Enein, MD, PhD, MSPH
Associate Professor of Clinical Medicine, Pediatrics, and Stem Cell Biology & Regenerative Medicine
Executive Director, Joint USC/CHLA Cell Therapy Program

and

Magdi Elsallab, MD
Regulatory Affairs and Clinical Development Specialist, Joint USC/CHLA Cell Therapy Program

• Identifying an appropriate development strategy for cell therapy products
• Outlining expected evidence that should be collected on a cell therapy candidate to satisfy regulatory requirements
• Addressing frequent challenges facing investigators during the development of cell therapies

Register today!